Senate Bill Would Eliminate Out-of-Pocket Costs for Follow-Up Breast Cancer Tests
A senate committee must act next: committee consideration.
No action since April 2025
This bill’s path across every version that has carried it.
How this policy affects specific groups of people
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Reps. Debbie Dingell and Beth Van Duyne discussed how the government shutdown is halting progress on the bipartisan Access to Breast Cancer Diagnosis Act. The bill seeks to eliminate out-of-pocket costs for follow-up diagnostic tests, a move supported by 90% of Republican voters in recent polls.
Lawmakers have reintroduced the Access to Breast Cancer Diagnosis Act, which would mandate that health insurers cover supplemental imaging services like MRI and ultrasound without patient cost-sharing. The bill aims to close the gap where follow-up tests are often not covered by the ACA.
The Access to Breast Cancer Diagnosis Act, led by Reps. Dingell and Fitzpatrick, seeks to eliminate financial barriers to diagnostic imaging. While screening mammograms are covered under current law, follow-up tests can cost patients over $1,000, leading many to forgo necessary care.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Access to Breast Cancer Diagnosis Act of 2025
Analysis generated by AI. Always verify with official sources.